在系统性红斑狼中准干扰素信号:从中吸取教训
Sarah A Jones1, Eric F Morand2,3,4
1Centre for Inflammatory Disease, Monash University, Clayton, Australia.
Drugs
|May 28, 2024
概括
1型干扰素 (IFN) 向是治疗系统性红斑狼 (SLE) 的一个有希望的新策略. 尽管面临挑战,但阻断IFN信号的疗法正在被证明是有效的,并为患者扩大治疗选择.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性红斑狼 (SLE) 的治疗选择有限,近几十年来批准的药物很少.
- 1型干扰素 (IFN) 在大多数SLE患者中始终被发现被激活,并发挥病原性作用.
- 以前针对SLE的药物开发还没有充分解决未满足的临床需求.
研究的目的:
- 审查1型干扰素 (IFN) 向治疗系统性红斑狼 (SLE) 的发展和疗效.
- 突出在SLE药物发现中针对1型IFN途径的挑战和成功.
- 讨论IFN向治疗在SLE治疗中的未来影响.
主要方法:
- 对针对SLE1型IFN通路的治疗方法的临床试验数据的审查.
- 对针对I型IFN受体的单克隆抗体anifrolumab的疗效和安全性的分析.
- 检查正在进行的对其他IFN向策略的研究,包括细胞和小分子方法.
主要成果:
- 阿尼弗罗卢马布在III期试验中显示出有效性,导致其在多个地区被批准用于SLE治疗.
- 虽然最初的IFN向剂显示出希望,但阻断I型IFN受体证明更成功.
- 随后对其他IFN途径抑制剂,包括TYK2抑制剂的II期试验产生了积极的结果.
结论:
- 准1型IFN通路代表了SLE治疗的重大进展.
- 尽管SLE临床试验存在复杂性,但针对IFN的治疗方法正在建立和扩展.
- 针对IFN的药物的开发为未来的SLE治疗策略提供了宝贵的教训.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K